Mckesson Corp.
- MCK · NYSE
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Irving, TX
- 43,000 employees
- CIK 0000927653
Updated from SEC filings through
Top things to know
Executives
- Brian Tyler Chair and chief executive officer 8-K, 2026-11-04
-
Brian S. Tyler Chief Executive Officer 4, 2026-07-08 - Kenny Cheung Executive vice president and chief financial officer 8-K, 2026-11-04
-
Kenny K. Cheung EVP & CFO 4, 2026-06-01 -
Britt J. Vitalone EVP & CFO 4, 2026-05-27 - James H. Hinton Executive Vice President and Chief Financial Officer (Principal Financial Officer) , Director 10-K, 2026-05-07
What leadership is saying
“McKesson delivered another quarter of strong results, reflecting operational strength in our core business segments and disciplined execution across the enterprise”
Earnings press release (8-K Ex. 99.1), filed November 4, 2026
Mckesson Corp is a U.S. public company in wholesale-drugs, proprietaries & druggists' sundries (SIC 5122), headquartered in Irving, TX. It trades as MCK on NYSE. Revenue was $403B in the fiscal year ending March 31, 2026, +12.4% from the year before. It reported about 43,000 employees. Brian Tyler is Chair and chief executive officer.
Five-year financials
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $403B 10-K, 2026-05-08 | $359B 10-K, 2026-05-08 | $309B 10-K, 2026-05-08 | $277B 10-K, 2025-05-09 | $264B 10-K, 2024-05-08 |
| Operating income | $6.2B 10-K, 2026-05-08 | $4.4B 10-K, 2026-05-08 | $3.9B 10-K, 2026-05-08 | $4.4B 10-K, 2025-05-09 | $2.0B 10-K, 2024-05-08 |
| SG&A | $8.1B 10-K, 2026-05-08 | $8.5B 10-K, 2026-05-08 | $8.7B 10-K, 2026-05-08 | $7.8B 10-K, 2025-05-09 | $10.5B 10-K, 2024-05-08 |
| Net income | $4.8B 10-K, 2026-05-08 | $3.3B 10-K, 2026-05-08 | $3.0B 10-K, 2026-05-08 | $3.6B 10-K, 2025-05-09 | $1.1B 10-K, 2024-05-08 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Brian Tyler | Chair and chief executive officer | 8-K, 2026-11-04 |
| Brian S. Tyler CEO at McKesson | Chief Executive Officer | 4, 2026-07-08 |
| Kenny Cheung | Executive vice president and chief financial officer | 8-K, 2026-11-04 |
| Kenny K. Cheung | EVP & CFO | 4, 2026-06-01 |
| Britt J. Vitalone | EVP & CFO | 4, 2026-05-27 |
| James H. Hinton | Executive Vice President and Chief Financial Officer (Principal Financial Officer) , Director | 10-K, 2026-05-07 |
 Ramesh (NMN) Srinivasan | EVP and Chief Strategy Officer | 4, 2026-08-11 |
| Ramesh Srinivasan EVP and Chief Strategy Officer at McKesson | Executive Vice President, Chief Strategy Officer | 8-K, 2026-07-01 |
 LeAnn B. Smith CHRO McKesson | EVP & Chief HR Officer | 4, 2026-06-02 |
 Michele Lau Executive Vice President and Chief Legal Officer | EVP and Chief Legal Officer | 4, 2026-05-27 |
| Donald R. Knauss | Senior Vice President and Controller (Principal Accounting Officer) , Director | 10-K, 2026-05-07 |
| Napoleon B. Rutledge JR SVP, Chief Accounting Officer and Controller - McKesson | SVP, Controller & CAO | 4, 2026-09-10 |
| Francisco Fraga Executive Vice President, Chief Information and Technology Officer at McKesson | EVP, CIO and CTO | 4, 2026-05-27 |
| Dominic J. Caruso | Board member (per proxy) bio: Lead Independent Director | DEF 14A, 2026-06-12 |
What Mckesson Corp does
McKesson Corporation together with its subsidiaries (collectively, the “Company,” “McKesson,” “we,” “our,” or “us” and other similar pronouns), which traces its business roots to 1833, is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable.
Shares and governance
| Shares outstanding | 115.5 million (as of October 30, 2026) | 10-Q, November 4, 2026 |
|---|---|---|
| Public float | $95.3B (as of September 30, 2025) | 10-K, May 8, 2026 |
| Reportable segments | 4 (period ending September 30, 2026) | 10-Q, November 4, 2026 |
| Latest proxy statement | Meeting March 31, 2026 (filed June 12, 2026) | DEF 14A, June 12, 2026 |
| Auditor | Deloitte & Touche LLP (Dallas, Texas) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| November 5, 2026 | Francisco Fraga EVP, CIO and CTO | Sale | 650 | $717K | Form 4, November 6, 2026 |
| November 4, 2026 | Francisco Fraga EVP, CIO and CTO | Sale | 600 | $630K | Form 4, November 5, 2026 |
| October 15, 2026 | Francisco Fraga EVP, CIO and CTO | Sale | 800 | $797K | Form 4, October 19, 2026 |
| September 8, 2026 | Napoleon B. Rutledge JR SVP, Controller & CAO | Sale | 111 | $99K | Form 4, September 10, 2026 |
| August 10, 2026 | Bradley E. Lerman Director | Sale | 301 | $269K | Form 4, August 11, 2026 |
| July 7, 2026 | Brian S. Tyler Chief Executive Officer | Sale | 8,463 | $6.7M | Form 4, July 8, 2026 |
| June 17, 2026 | Brian S. Tyler Chief Executive Officer | Sale | 8,463 | $6.6M | Form 4, June 18, 2026 |
| June 9, 2026 | Brian S. Tyler Chief Executive Officer | Sale | 4,929 | $3.8M | Form 4, June 11, 2026 |
Recent 8-K events
- 8-K filed 2026-11-04
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-10-06
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-28
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-05
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-07-24
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-07-01
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-06-12
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- 8-K filed 2026-05-07
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-04-28
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- 8-K filed 2026-04-06
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
Frequently asked questions about Mckesson Corp
- What does Mckesson Corp do?
- In its own words, from Item 1 of its 10-K: "McKesson Corporation together with its subsidiaries (collectively, the “Company,” “McKesson,” “we,” “our,” or “us” and other similar pronouns), which traces its business roots to 1833, is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable."
- What is Mckesson Corp's revenue?
- $403B for the fiscal year ending March 31, 2026, from its 10-K filed May 8, 2026.
- Is Mckesson Corp profitable?
- Mckesson Corp reported net income of $4.8B for the fiscal year ending March 31, 2026.
- How many employees does Mckesson Corp have?
- About 43,000 as of March 31, 2026, as stated in its annual report.
- Who is the CEO of Mckesson Corp?
- Brian Tyler, Chair and chief executive officer, as named in a 8-K filed November 4, 2026.
- Who is the CFO of Mckesson Corp?
- Kenny Cheung, Executive vice president and chief financial officer, as named in a 8-K filed November 4, 2026.
- Where is Mckesson Corp headquartered?
- Irving, TX.
- What is Mckesson Corp's stock ticker?
- MCK on NYSE.
- What industry is Mckesson Corp in?
- Wholesale-Drugs, Proprietaries & Druggists' Sundries, SIC code 5122.
- What is Mckesson Corp's website?
- mckesson.com. Investor relations: https://investor.mckesson.com/overview/default.aspx.
- When does Mckesson Corp report earnings next?
- February 3, 2027. Source: estimate_8k_pattern.
- Is Mckesson Corp a public company?
- Yes. Mckesson Corp files with the SEC under CIK 0000927653 and trades as MCK.
- Who audits Mckesson Corp?
- Deloitte & Touche LLP, Dallas, Texas, as named in its latest annual report (10-K).
- How many shares of Mckesson Corp are outstanding?
- 115.5 million shares as of October 30, 2026, from its 10-Q filed November 4, 2026.
- What is Mckesson Corp's public float?
- $95.3B as of September 30, 2025, as reported on the cover of its 10-K filed May 8, 2026.
- How many business segments does Mckesson Corp report?
- 4 reportable segments for the period ending September 30, 2026, from its 10-Q filed November 4, 2026.
- When is Mckesson Corp's annual shareholder meeting?
- March 31, 2026, per its proxy statement (DEF 14A) filed June 12, 2026.
- Have Mckesson Corp insiders traded stock recently?
- Since July 11, 2025, officers and directors reported 24 open-market sales worth about $60.9M and 0 purchases on Forms 4 and 5. The most recent: Francisco Fraga (EVP, CIO and CTO) sold 650 shares on November 5, 2026.